Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration
2023-02-22 22:00
150th Anniversary of Dr. Hansen's Discovery of M. leprae Is Opportunity to Examine Past, Present and Future of Leprosy
2023-02-22 22:00
GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate
2023-02-22 21:00
Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA
2023-02-22 20:17
Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment for Phase III clinical trial for the gene therapy treatment of LHON
2023-02-21 21:30
NMPA accepted the registration applications for Uro-G and Uro-3500
2023-02-21 17:46
RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore
2023-02-21 10:00
Bridge Biotherapeutics Presents Phase 2a Clinical Trial Results For BBT-401, a Drug Candidate to Treat Ulcerative Colitis
2023-02-21 07:00
EDAN Pictured the Long-Term Regional Development Plans with the Minister Counselor of the Chinese Embassy in Kenya
2023-02-21 00:15
Celltrion and LISCure Biosciences announce strategic collaboration to develop novel microbiome treatment for Parkinson's disease
2023-02-20 22:00
Daewoong Pharmaceutical Reaches Sales of KRW 1.16 Trillion in 2022, Fexuclue Leads The Highest Revenue
2023-02-20 12:29
GC Biopharma Receives WHO Pre-Qualification for BARYCELA
2023-02-20 09:38
Qilian International Holding Group Ltd Declares Special Cash Dividends to Shareholders
2023-02-17 05:30
GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS
2023-02-17 03:00
111, Inc. Hosts Hua Medicine Launches First Official Flagship Store
2023-02-16 13:33
Randomized Controlled Trial Backs Clinical Efficacy of Lunit AI for Chest X-Ray
2023-02-13 21:00
B dot Medical to Install Ultra-compact Proton Therapy System at Thammasat University in Thailand
2023-02-13 14:00
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities
2023-02-10 20:00
Nona Biosciences Enters into HCAb Based Antibody Discovery Collaboration Agreement with Mythic Therapeutics
2023-02-10 13:00
US based COBRA diagnostic prostate cancer trial reaches recruitment target
2023-02-09 22:03
1
57
58
59
60
61
165